The 2019 novel coronavirus, or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a positive sense, single-stranded RNA coronavirus. It has been named officially as the COVID-19 by the WHO.
Leading healthcare experts from around the world are working closely on this new virus, tracking its spreading and virulence, and providing advice to individuals on how to protect oneself and prevent it from spreading further.
Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to the more severe such as Middle East Respiratory Syndrome (MERS-CoV), Severe Acute Respiratory Syndrome (SARS-CoV), and the current SARS-CoV-2. Symptoms can vary in different species. So far, no vaccines or antiviral drugs have been developed to prevent or treat human coronavirus infections.
SARS-CoV-2 is enveloped, spherical of 60-140 nm in diameter with spikes of about 9-12 nm. The spike protein (S-protein) mediates receptor binding and membrane fusion which is the common target for neutralizing antibodies and vaccines. It’s been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor.
Creative BioMart is fully supportive to the COVID-19 research. Taking advantage of our scientific expertise, high-quality products, and abundant experience, we are glad to provide a full set of the SARS-CoV-2 recombinant proteins, including full length S protein (ECD), the S1 subunit, the S2 subunit, the S1 RBD, the N protein, and the possible target ACE2.
Besides, Creative BioMart also provides SARS-CoV, MERS-CoV, and other CoV related proteins to build on the existing SARS and MERS coronavirus research and identify knowledge gaps and research priorities to minimize the impact of the COVID-19 outbreak.